STEPHANIE ARKIN: Open Payments
NPI 1356996565 · SUWANEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,605 in 88 payments from 19 companies in 2025. Trend: 2023 $582 · 2024 $520 · 2025 $1,605
Food & beverage: $1,496Education: $109
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 13 | $292 |
| Otsuka America Pharmaceutical, Inc. | 16 | $286 |
| Teva Pharmaceuticals USA, Inc. | 10 | $218 |
| Supernus Pharmaceuticals, Inc. | 13 | $162 |
| Axsome Therapeutics, Inc. | 4 | $104 |
| ABBVIE INC. | 5 | $82 |
| Lundbeck LLC | 4 | $79 |
| Tris Pharma Inc | 4 | $77 |
| Alkermes, Inc. | 2 | $52 |
| Corium, LLC | 7 | $50 |
Products named: INGREZZA, REXULTI, Qelbree, Auvelity, VRAYLAR, ABILIFY ASIMTUFII, AUSTEDO XR, Dyanavel XR.
Industry payments across GA — which companies pay providers there.
